TP53 and neoplasm: Furthermore, an expanding body of work indicates that oncogenic drivers like MYC and mTOR can upregulate ribosomal RNA transcription, while tumor suppressors (e.g., p53) often act as “nucleolar guardians” to restrain ribosome production [7,9,22].